Maxillary osteonecrosis associated to antiangiogenic drugs.
Cesar
C
Salort-Llorca
Mari-Paz
MP
Mínguez-Serra
Francisco-Javier
FJ
Silvestre-Donat
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D008439:Maxillary Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab